On the evening of August 27, the 2025 Frost & Sullivan Global Growth, Innovation and Leadership Awards for China and Best Practices were grandly announced at the 2025 Frost & Sullivan Global Growth, Innovation and Leadership Awards Ceremony and VIP Reception.
Based on recent research and analysis of the global high-end hyaluronic acid technology market, as well as studies and evaluations of related companies in the industry, Frost & Sullivan awarded Haohai Bio-Tech the '2025 Global High-End Hyaluronic Acid Technology Leadership Award'. Hazmi Yusof, Senior Vice President and Malaysia Country Head at Frost & Sullivan, and Professor Wang Yu, President of the China Liver Disease Prevention and Control Foundation, an expert advisor to the Frost & Sullivan Global Expert Advisory Group, and winner of the 2024 Frost & Sullivan Greater China Special Contribution Award, presented the award on behalf of Haohai Bio-Tech.
Haohai Biosciences
"2025 Global Advanced HA Technology Leadership Award"
Hazmi Yusof, Senior Vice President and Malaysia Head of Frost & Sullivan, and Professor Wang Yu, Chairman of the China Hepatitis Prevention and Control Foundation, an expert consultant to the Frost & Sullivan Global Expert Advisory Group, and winner of the 2024 Frost & Sullivan Greater China Special Contribution Award, presented awards on behalf of HaoHaiShengke.
Haohai Bio-Technology Co., Ltd. is a globally leading biomedical materials platform company, driving rapid growth in both medical aesthetics and ophthalmology through 'multidisciplinary integration + full industrial chain integration'.
Haohai Bio-Tech was established in 2007 and went public on the Hong Kong Main Board in 2015 and on the Sci-tech Innovation Board in 2019. It is the only domestic technology innovation group that has integrated five core raw materials and end products: hyaluronic acid, chitosan, gene-engineered drugs, intraocular lenses, and orthokeratology lenses. Relying on a closed-loop R&D architecture of 'synthetic biology - materials science - tissue engineering - optoelectronic technology', the company has built a full product line covering four high-growth sectors: ophthalmology, medical aesthetics, orthopedics, anti-adhesion, and hemostasis. It has achieved import substitution and led the industry in key areas such as hyaluronic acid cross-linking technology, degradable chitosan, hydrophobic/hydrophilic intraocular lenses, and high oxygen permeability contact lenses.
Deeply involved in the medical aesthetics injection field, we have established a new benchmark for the technology of 'Amino acid cross-linking + granule-free'.
In the field of medical aesthetics, Haohai Bio-tech has reached strategic cooperation with top global dermatologists, medical aesthetic institutions, and regenerative medicine laboratories, dedicated to advancing hyaluronic acid towards a safer, more durable, and more natural paradigm through cross-linking technology iterations. In September 2024, Haohai launched the world's first amino acid cross-linked hyaluronic acid filler - Haimei Moon White.®It has become a benchmark practice in the industry. This product deeply integrates lysine cross-linking with enzyme digestion site protection technology. It is equipped with a highly cohesive particle-free gel structure. On the basis of ensuring the dual advantages of 'zero residue' of the cross-linking agent and 'collagen-promoting' degradation products, it achieves mechanical properties surpassing traditional BDDE processes and long-term maintenance for 12 - 18 months. It can significantly improve injection safety and patient satisfaction.
The modular product matrix supports diversified expansion, with continuous layout in global regulatory markets.
The medical aesthetics and ophthalmology products developed by Haohai Shengke are modular in design, featuring three interchangeable modules: 'cross-linking degree - viscoelasticity - degradation sequence'. They possess highly flexible configuration capabilities and the advantage of rapid conversion to multiple national regulations. The core lies in the deep coupling of raw materials - instruments - and optoelectronic equipment, enabling customized joint solutions for facial rejuvenation and refractive correction. The products are highly standardized, capable of switching between different specifications of 2ml to 3ml on the same production line, supporting large-scale industrial expansion.
About the Frost & Sullivan Global Technology Leadership Award
The Frost & Sullivan Global Technology Leadership Award recognizes outstanding performance and achievements in technology innovation, market potential, customer service, brand, and other aspects by companies. The Frost & Sullivan team has nominated a group of competitive and excellent enterprises to the independent judging panel through methods such as in-depth interviews, industry analysis, and secondary research. An independent judging panel composed of third-party investment and financing experts, financial specialists, bankers, and renowned listed entrepreneurs conducts a rigorous review of the enterprises nominated by the Frost & Sullivan team, deciding to award the '2025 Global High-End Hyaluronic Acid Technology Leadership Award' to Haohaiseng Biotechnology.
